Clinical trial
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane…
NCT00434083 · POZEN, Industry · Completed
Key facts
| NCT number | NCT00434083 |
|---|---|
| Title | To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches |
| Official title | A Double-Blind Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches |
| Lead sponsor | POZEN, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Headaches |
| Intervention type | Drug |
| Interventions | sumatriptan, naproxen sodium |
| Enrollment | 1,200 |
| Start date | Jul 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | Feb 12, 2007 |
| Last update posted | Feb 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: